Liver-Targeted Tolerogenic Lipid Nanoparticles for Treating Autoimmune Diseases
International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-22
DOI: 10.2147/ijn.s619772 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Hemant Singh und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Singh, H., Singh, S. S., Sawant, V., Sharma, C., Khan, H., Veettil, R. M., Upadhyay, T. K., Banat, F., & Hassan, S. (2026). Liver-Targeted Tolerogenic Lipid Nanoparticles for Treating Autoimmune Diseases. International Journal of Nanomedicine, Volume 21, 1-22. https://doi.org/10.2147/ijn.s619772
Vancouver
Singh H, Singh SS, Sawant V, Sharma C, Khan H, Veettil RM, et al. Liver-Targeted Tolerogenic Lipid Nanoparticles for Treating Autoimmune Diseases. International Journal of Nanomedicine. 2026;Volume 21:1-22. doi:10.2147/ijn.s619772
BibTeX
@article{Singh2026,
author = {Singh, Hemant and Singh, Sarthak Samuel and Sawant, Vikram and Sharma, Chhavi and Khan, Hina and Veettil, Rukshana Mangattu and Upadhyay, Tarun Kumar and Banat, Fawzi and Hassan, Shabir},
title = {Liver-Targeted Tolerogenic Lipid Nanoparticles for Treating Autoimmune Diseases},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--22},
doi = {10.2147/ijn.s619772}
}
EUVIMED